Reducing sensory eye dominance with learning protocol

Article

A recent study revealed a novel push-pull training protocol that was designed to reduce sensory eye dominance (SED).

A recent study, published in Current Biology, revealed a novel push-pull training protocol that was designed to reduce sensory eye dominance (SED), which is mainly caused by unbalanced interocular inhibition.

The training involved a cue that stimulated the weak eye (push) while causing interocular inhibition of the strong eye (pull). It was found that the protocol reduced SED and improved stereopsis better than the push only protocol, which only stimulates the weak eye without inhibiting the strong eye.

Additionally, it was indicated in the study that the design of this protocol could be used as a non-invasive treatment of amblyopia.

If you would like to learn more please click here

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.